Want to join the conversation?
$ACM's wins for 2Q16 of $2.7Bil were driven primarily by the Americas business within the Design and Consulting Services segment. The company's total backlog of $38.6Bil decreased 4% from the prior quarter. Including the $1.1Bil of construction value not reflected in its backlog, wins were $3.8Bil and backlog would have been $39.7Bil.
$WBA is yet to receive US anti-trust clearance for its Rite Aid acquisition. The deadline for the deal expires on January 27.
$BMY plunge 7.2%. No credits to the non-acceleration of approval for lung cancer combination treatment.
Well this is big! I don’t know if it’s someone’s monopoly or genuine excitement, but either way, $CSX is up 23% after market closed. I heard some activist investor is going to blow big money into CSX Corp. Anyone mind explaining?